ImmunologybioRxivPreprint
Optimization of an LNP-mRNA vaccine candidate targeting SARS-CoV-2 receptor-binding domain
K. Kobiyama, M. Imai, N. Jounai…·K. J. Ishii
This study optimizes an LNP-mRNA vaccine targeting SARS-CoV-2 RBD by removing reactogenic materials, improving immunogenicity and protection in macaques.
DOI 10.1101/2021.03.04.433852